Review

New therapeutic targets in giant-cell arteritis. Considerations based on the current pathogenic model and the availability of new therapeutic agents

E. Lozano, M. Segarra, A. García-Martínez, G. Espígol-Frigolé, J. Hernández-Rodríguez, M.C. Cid

Department of Systemic Autoimmune Diseases, Clinical Institute of Medicine and Dermatology, Hospital Clínic, University of Barcelona, Institut d’Investigacions Biomèdiques, Barcelona, Spain.

Key words

Vasculitis, pathogenesis, cytokines, biologic therapies.

Please address correspondence to: Maria C. Cid, MD, Department of Systemic Autoimmune Diseases, Clinical Institute of Medicine and Dermatology, Hospital Clínic, Villarroel 170, 08036-Barcelona, Spain.

E-mail: mccid@clinic.ub.es

Clin Exp Rheumatol 2008; 26 (Suppl. 49): S-141-S-150